NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/06/2020
Back to search
Official data from USPTO
THE DR. BOB SHOW
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
THE DR. BOB SHOW
ST13
US500000076666952Class
41
Filing
76666952
Registration
3891633
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
03/06/2020
Trademark type
Word
Nice classes
41
Filing date
10/03/2006
Registration date
12/21/2010
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/06/2020
Last transaction
03/06/2020
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
08/12/1997
First use in commerce
08/12/1997
Drawing code
4
Owner type
03
Owner location
Knoxville, TN, US
Examiner
STEIN, JAMES W
Law office
L70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
RMO Productions, Inc.
Representatives
Wade R. Orr Luedeka Neely Group, P.C.
Technical classification
Nice Classes
Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 41
education and entertainment servicesa series of television programs covering a range of medical and health-related topics of interest to the general public
Publications
History of USPTO decisions and trademark events.
42 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/06/2020
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/06/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/06/2020
E89R
TEAS SECTION 8 & 9 RECEIVED
01/15/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/21/2019
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/09/2016
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/09/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/02/2016
E815
TEAS SECTION 8 & 15 RECEIVED
12/29/2015
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/21/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/22/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
12/21/2010
PUBO
PUBLISHED FOR OPPOSITION
10/05/2010
NPUB
NOTICE OF PUBLICATION
09/15/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/02/2010
ALIE
ASSIGNED TO LIE
09/02/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/20/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/19/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/19/2010
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
08/19/2010
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
03/23/2010
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
09/23/2009
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
03/23/2009
ALIE
ASSIGNED TO LIE
03/23/2009
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
09/22/2008
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
03/21/2008
ALIE
ASSIGNED TO LIE
03/12/2008
CNSL
LETTER OF SUSPENSION MAILED
09/12/2007
CNSL
SUSPENSION LETTER WRITTEN
09/12/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/22/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/22/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/22/2007
CNRT
NON-FINAL ACTION MAILED
02/22/2007
CNRT
NON-FINAL ACTION WRITTEN
02/22/2007
DOCK
ASSIGNED TO EXAMINER
02/21/2007
FFDM
FILING RECEIPT CORRECTION ENTERED
01/11/2007
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
11/30/2006
ALIE
ASSIGNED TO LIE
11/30/2006
FAXX
FAX RECEIVED
11/08/2006
MAFR
APPLICATION FILING RECEIPT MAILED
10/17/2006
NWAP
NEW APPLICATION ENTERED
10/11/2006
Continuous trademark protection
Get notified about every new filing that threatens THE DR. BOB SHOW or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.